{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:29:33Z","timestamp":1794428973290,"version":"4.9.1"},"publisher-location":"Berlin, Heidelberg","reference-count":91,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642354243","type":"print"},{"value":"9783642354250","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/7854_2012_209","type":"book-chapter","created":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T23:51:53Z","timestamp":1345247513000},"page":"291-307","source":"Crossref","is-referenced-by-count":6,"title":["New Approaches in the Treatment of Bipolar Depression"],"prefix":"10.1007","author":[{"given":"Kate E. A.","family":"Saunders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M.","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,19]]},"reference":[{"key":"209_CR1","doi-asserted-by":"publisher","first-page":"807","DOI":"10.4088\/JCP.v63n0910","volume":"63","author":"LL Altshuler","year":"2002","unstructured":"Altshuler LL, Gitlin MJ, Mintz J, Leight KL, Frye MA (2002) Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J Clin Psychiatry 63:807\u2013811","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"209_CR2","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1177\/0269881110376695","volume":"25","author":"B Amann","year":"2010","unstructured":"Amann B, Born C, Crespo JM, Pomarol-Clotet E, Mckenna P (2010) Lamotrigine: when and where does it act in affective disorders? A systematic review. J Psychopharmacol 25(10):1289\u20131294","journal-title":"J Psychopharmacol"},{"key":"209_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/0269881107088441","volume":"22","author":"IM Anderson","year":"2008","unstructured":"Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, Matthews K, Mcallister-Williams RH, Peveler RC, Scott J, Tylee A (2008) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 22:343\u2013396","journal-title":"J Psychopharmacol"},{"key":"209_CR4","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1097\/00001756-200008030-00029","volume":"11","author":"OA Andreassen","year":"2000","unstructured":"Andreassen OA, Dedeoglu A, Klivenyi P, Beal MF, Bush AI (2000) N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis. NeuroReport 11:2491\u20132493","journal-title":"NeuroReport"},{"key":"209_CR5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1176\/appi.ps.57.7.937","volume":"57","author":"MS Bauer","year":"2006","unstructured":"Bauer MS, Mcbride L, Williford WO, Glick H, Kinosian B, Altshuler L, Beresford T, Kilbourne AM, Sajatovic M (2006) Collaborative care for bipolar disorder: part II. Impact on clinical outcome, function, and costs. Psychiatr Serv 57:937\u2013945","journal-title":"Psychiatr Serv"},{"key":"209_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2165\/00023210-200721090-00003","volume":"21","author":"F Benazzi","year":"2007","unstructured":"Benazzi F (2007) Bipolar II disorder: epidemiology, diagnosis and management. CNS Drugs 21:727\u2013740","journal-title":"CNS Drugs"},{"key":"209_CR7","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","volume":"64","author":"M Berk","year":"2008","unstructured":"Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI (2008) N-acetyl cysteine for depressive symptoms in bipolar disorder\u2014a double-blind randomized placebo-controlled trial. Biol Psychiatry 64:468\u2013475","journal-title":"Biol Psychiatry"},{"key":"209_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1586\/14737175.2.2.239","volume":"2","author":"Z Bhagwagar","year":"2002","unstructured":"Bhagwagar Z, Goodwin GM (2002) Role of mood stabilizers in bipolar disorder. Expert Rev Neurother 2:239\u2013248","journal-title":"Expert Rev Neurother"},{"key":"209_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jad.2009.11.008","volume":"124","author":"DJ Bond","year":"2010","unstructured":"Bond DJ, Lam RW, Yatham LN (2010) Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis. J Affect Disord 124:228\u2013234","journal-title":"J Affect Disord"},{"key":"209_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","volume":"57","author":"CL Bowden","year":"2000","unstructured":"Bowden CL, Calabrese JR, Mcelroy SL, Gyulai L, Wassef A, Petty F, Pope HG Jr, Chou JC, Keck PE Jr, Rhodes LJ, Swann AC, Hirschfeld RM, Wozniak PJ (2000) A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex maintenance study group. Arch Gen Psychiatry 57:481\u2013489","journal-title":"Arch Gen Psychiatry"},{"key":"209_CR11","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/npp.2009.191","volume":"35","author":"BP Brennan","year":"2010","unstructured":"Brennan BP, Hudson JI, Jensen JE, Mccarthy J, Roberts JL, Prescot AP, Cohen BM, Pope HG Jr, Renshaw PF, Ongur D (2010) Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology 35:834\u2013846","journal-title":"Neuropsychopharmacology"},{"key":"209_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.4088\/JCP.v67n0703","volume":"67","author":"EB Brown","year":"2006","unstructured":"Brown EB, Mcelroy SL, Keck PE Jr, Deldar A, Adams DH, Tohen M, Williamson DJ (2006) A 7\u00a0week, randomized, double-blind trial of olanzapine\/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiatry 67:1025\u20131033","journal-title":"J Clin Psychiatry"},{"key":"209_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1399-5618.2007.00507.x","volume":"9","author":"JR Calabrese","year":"2007","unstructured":"Calabrese JR, Guelfi JD, Perdrizet-Chevallier C (2007) Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data. Bipolar Disord 9:628\u2013635","journal-title":"Bipolar Disord"},{"key":"209_CR14","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.4088\/JCP.v65n1109","volume":"65","author":"JR Calabrese","year":"2004","unstructured":"Calabrese JR, Hirschfeld RM, Frye MA, Reed ML (2004) Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample. J Clin Psychiatry 65:1499\u20131504","journal-title":"J Clin Psychiatry"},{"key":"209_CR15","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1176\/appi.ajp.162.11.2152","volume":"162","author":"JR Calabrese","year":"2005","unstructured":"Calabrese JR, Shelton MD, Rapport DJ, Youngstrom EA, Jackson K, Bilali S, Ganocy SJ, Findling RL (2005) A 20\u00a0month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry 162:2152\u20132161","journal-title":"Am J Psychiatry"},{"key":"209_CR16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.4088\/JCP.v61n1106","volume":"61","author":"JR Calabrese","year":"2000","unstructured":"Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, Mcelroy SL, Kusumakar V, Ascher JA, Earl NL, Greene PL, Monaghan ET (2000) A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 61:841\u2013850","journal-title":"J Clin Psychiatry"},{"key":"209_CR17","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/archpsyc.63.7.741","volume":"63","author":"DM Cannon","year":"2006","unstructured":"Cannon DM, Carson RE, Nugent AC, Eckelman WC, Kiesewetter DO, Williams J, Rollis D, Drevets M, Gandhi S, Solorio G, Drevets WC (2006) Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder. Arch Gen Psychiatry 63:741\u2013747","journal-title":"Arch Gen Psychiatry"},{"key":"209_CR18","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.pnpbp.2010.07.020","volume":"34","author":"JS Chang","year":"2010","unstructured":"Chang JS, Moon E, Cha B, Ha K (2010) Adjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizers. Prog Neuropsychopharmacol Biol Psychiatry 34:1322\u20131326","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"209_CR19","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1176\/appi.ajp.162.10.1805","volume":"162","author":"A Cipriani","year":"2005","unstructured":"Cipriani A, Pretty H, Hawton K, Geddes JR (2005) Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 162:1805\u20131819","journal-title":"Am J Psychiatry"},{"key":"209_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/archpsyc.60.4.402","volume":"60","author":"F Colom","year":"2003","unstructured":"Colom F, Vieta E, Martinez-Aran A, Reinares M, Goikolea JM, Benabarre A, Torrent C, Comes M, Corbella B, Parramon G, Corominas J (2003) A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 60:402\u2013407","journal-title":"Arch Gen Psychiatry"},{"key":"209_CR21","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","volume":"67","author":"N Diazgranados","year":"2010","unstructured":"Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, khalife S, Kammerer WA, Kammerer WA, Quezado Z, Luckenbaugh DA, Salvadore G, Machado-Vieira R, Manji HK, Zarate CA Jr (2010) A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67:793\u2013802","journal-title":"Arch Gen Psychiatry"},{"key":"209_CR22","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1517\/14656566.2010.490831","volume":"11","author":"A Fagiolini","year":"2010","unstructured":"Fagiolini A, Casamassima F, Mostacciuolo W, Forgione R, Goracci A, Goldstein BI (2010) Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder. Expert Opin Pharmacother 11:1727\u20131740","journal-title":"Expert Opin Pharmacother"},{"key":"209_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1192\/bjp.188.1.46","volume":"188","author":"S Frangou","year":"2006","unstructured":"Frangou S, Lewis M, Mccrone P (2006) Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry 188:46\u201350","journal-title":"Br J Psychiatry"},{"key":"209_CR24","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/archpsyc.62.9.996","volume":"62","author":"E Frank","year":"2005","unstructured":"Frank E, Kupfer DJ, Thase ME, Mallinger AG, Swartz HA, Fagiolini AM, Grochocinski V, Houck P, Scott J, Thompson W, Monk T (2005) Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry 62:996\u20131004","journal-title":"Arch Gen Psychiatry"},{"key":"209_CR25","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1176\/appi.ajp.2007.06060981","volume":"164","author":"MA Frye","year":"2007","unstructured":"Frye MA, Grunze H, Suppes T, Mcelroy SL, Keck PE Jr, Walden J, Leverich GS, Altshuler LL, Nakelsky S, Hwang S, Mintz J, Post RM (2007) A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry 164:1242\u20131249","journal-title":"Am J Psychiatry"},{"key":"209_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejphar.2007.10.023","volume":"578","author":"E Fumagalli","year":"2008","unstructured":"Fumagalli E, Funicello M, Rauen T, Gobbi M, Mennini T (2008) Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. Eur J Pharmacol 578:171\u2013176","journal-title":"Eur J Pharmacol"},{"key":"209_CR27","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1038\/npp.2010.131","volume":"35","author":"ML Furey","year":"2010","unstructured":"Furey ML, Khanna A, Hoffman EM, Drevets WC (2010) Scopolamine produces larger antidepressant and antianxiety effects in women than in men. Neuropsychopharmacology 35:2479\u20132488","journal-title":"Neuropsychopharmacology"},{"key":"209_CR28","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2147\/NDT.S1636","volume":"3","author":"P Gajwani","year":"2007","unstructured":"Gajwani P, Muzina DJ, Kemp DE, Gao K, Calabrese JR (2007) Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies. Neuropsychiatr Dis Treat 3:847\u2013853","journal-title":"Neuropsychiatr Dis Treat"},{"key":"209_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1192\/bjp.bp.107.048504","volume":"194","author":"JR Geddes","year":"2009","unstructured":"Geddes JR, Calabrese JR, Goodwin GM (2009) Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 194:4\u20139","journal-title":"Br J Psychiatry"},{"key":"209_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0140-6736(10)60570-3","volume":"375","author":"JR Geddes","year":"2010","unstructured":"Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E (2010) Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 375:385\u2013395","journal-title":"Lancet"},{"key":"209_CR31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4088\/JCP.v62n07a12","volume":"62","author":"SN Ghaemi","year":"2001","unstructured":"Ghaemi SN, Lenox MS, Baldessarini RJ (2001) Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry 62:565\u2013569","journal-title":"J Clin Psychiatry"},{"key":"209_CR32","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1176\/appi.ajp.161.9.1537","volume":"161","author":"HJ Gijsman","year":"2004","unstructured":"Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM (2004) Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 161:1537\u20131547","journal-title":"Am J Psychiatry"},{"key":"209_CR33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1176\/appi.ajp.161.3.564","volume":"161","author":"JF Goldberg","year":"2004","unstructured":"Goldberg JF, Burdick KE, Endick CJ (2004) Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Am J Psychiatry 161:564\u2013566","journal-title":"Am J Psychiatry"},{"key":"209_CR34","doi-asserted-by":"publisher","first-page":"432","DOI":"10.4088\/JCP.v65n0321","volume":"65","author":"GM Goodwin","year":"2004","unstructured":"Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, Greene P, Leadbetter R (2004) A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 65:432\u2013441","journal-title":"J Clin Psychiatry"},{"key":"209_CR35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00004850-199914050-00003","volume":"14","author":"W Greil","year":"1999","unstructured":"Greil W, Kleindienst N (1999) Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. Int Clin Psychopharmacol 14:283\u2013285","journal-title":"Int Clin Psychopharmacol"},{"key":"209_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0165-0327(96)01427-9","volume":"43","author":"W Greil","year":"1997","unstructured":"Greil W, Ludwig-Mayerhofer W, Erazo N, Schochlin C, Schmidt S, Engel RR, Czernik A, Giedke H, Muller-Oerlinghausen B, Osterheider M, Rudolf GA, Sauer H, Tegeler J, Wetterling T (1997) Lithium versus carbamazepine in the maintenance treatment of bipolar disorders\u2013a randomised study. J Affect Disord 43:151\u2013161","journal-title":"J Affect Disord"},{"key":"209_CR37","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.pnpbp.2007.04.017","volume":"31","author":"C Han","year":"2007","unstructured":"Han C, Lee MS, Pae CU, Ko YH, Patkar AA, Jung IK (2007) Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 31:1219\u20131223","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"209_CR38","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4088\/JCP.v64n0206","volume":"64","author":"EG Hartong","year":"2003","unstructured":"Hartong EG, Moleman P, Hoogduin CA, Broekman TG, Nolen WA (2003) Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. J Clin Psychiatry 64:144\u2013151","journal-title":"J Clin Psychiatry"},{"key":"209_CR39","first-page":"58","volume":"14","author":"DS Janowsky","year":"1978","unstructured":"Janowsky DS, Davis JM (1978) Adrenergic-cholinergic balance in affective disorders. Psychopharmacol Bull 14:58\u201360","journal-title":"Psychopharmacol Bull"},{"key":"209_CR40","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1037\/0021-843X.106.3.449","volume":"106","author":"SL Johnson","year":"1997","unstructured":"Johnson SL, Miller I (1997) Negative life events and time to recovery from episodes of bipolar disorder. J Abnorm Psychol 106:449\u2013457","journal-title":"J Abnorm Psychol"},{"key":"209_CR41","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1037\/0033-2909.117.3.434","volume":"117","author":"SL Johnson","year":"1995","unstructured":"Johnson SL, Roberts JE (1995) Life events and bipolar disorder: implications from biological theories. Psychol Bull 117:434\u2013449","journal-title":"Psychol Bull"},{"key":"209_CR42","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/archpsyc.60.3.261","volume":"60","author":"LL Judd","year":"2003","unstructured":"Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, Maser JD, Solomon DA, Leon AC, Keller MB (2003) A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 60:261\u2013269","journal-title":"Arch Gen Psychiatry"},{"key":"209_CR43","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.4088\/JCP.v68n1003","volume":"68","author":"PE Keck Jr","year":"2007","unstructured":"Keck PE Jr, Calabrese JR, Mcintyre RS, Mcquade RD, Carson WH, Eudicone JM, Carlson BX, Marcus RN, Sanchez R (2007) Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry 68:1480\u20131491","journal-title":"J Clin Psychiatry"},{"key":"209_CR44","doi-asserted-by":"publisher","first-page":"626","DOI":"10.4088\/JCP.v67n0414","volume":"67","author":"PE Keck Jr","year":"2006","unstructured":"Keck PE Jr, Calabrese JR, Mcquade RD, Carson WH, Carlson BX, Rollin LM, Marcus RN, Sanchez R (2006a) A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J Clin Psychiatry 67:626\u2013637","journal-title":"J Clin Psychiatry"},{"key":"209_CR45","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.biopsych.2006.03.056","volume":"60","author":"PE Keck Jr","year":"2006","unstructured":"Keck PE Jr, Mintz J, Mcelroy SL, Freeman MP, Suppes T, Frye MA, Altshuler LL, Kupka R, Nolen WA, Leverich GS, Denicoff KD, Grunze H, Duan N, Post RM (2006b) Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry 60:1020\u20131022","journal-title":"Biol Psychiatry"},{"key":"209_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0006-3223(00)00975-6","volume":"49","author":"TA Ketter","year":"2001","unstructured":"Ketter TA, Kimbrell TA, George MS, Dunn RT, Speer AM, Benson BE, Willis MW, Danielson A, Frye MA, Herscovitch P, Post RM (2001) Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry 49:97\u2013109","journal-title":"Biol Psychiatry"},{"key":"209_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000202824","volume":"59","author":"I Koszewska","year":"2009","unstructured":"Koszewska I, Rybakowski JK (2009) Antidepressant-induced mood conversions in bipolar disorder: a retrospective study of tricyclic versus non-tricyclic antidepressant drugs. Neuropsychobiology 59:12\u201316","journal-title":"Neuropsychobiology"},{"key":"209_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/archpsyc.60.2.145","volume":"60","author":"DH Lam","year":"2003","unstructured":"Lam DH, Watkins ER, Hayward P, Bright J, Wright K, Kerr N, Parr-Davis G, Sham P (2003) A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry 60:145\u2013152","journal-title":"Arch Gen Psychiatry"},{"key":"209_CR49","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4088\/JCP.v64n0503","volume":"64","author":"GS Leverich","year":"2003","unstructured":"Leverich GS, Altshuler LL, Frye MA, Suppes T, Keck PE, Mcelroy SL, Denicoff KD, Obrocea G, Nolen WA, Kupka R, Walden J, Grunze H, Perez S, Luckenbaugh DA, Post RM (2003) Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. J Clin Psychiatry 64:506\u2013515","journal-title":"J Clin Psychiatry"},{"key":"209_CR50","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1176\/appi.ajp.163.2.232","volume":"163","author":"GS Leverich","year":"2006","unstructured":"Leverich GS, Altshuler LL, Frye MA, Suppes T, Mcelroy SL, Keck PE Jr, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM (2006) Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 163:232\u2013239","journal-title":"Am J Psychiatry"},{"key":"209_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1192\/bjp.bp.110.086983","volume":"200","author":"CT Li","year":"2012","unstructured":"Li CT, Bai YM, Huang YL, Chen YS, Chen TJ, Cheng JY, Su TP (2012) Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study. Br J Psychiatry 200:45\u201351","journal-title":"Br J Psychiatry"},{"key":"209_CR52","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/1073858409336093","volume":"15","author":"R Machado-Vieira","year":"2009","unstructured":"Machado-Vieira R, Manji HK, Zarate CA (2009) The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders. Neuroscientist 15:525\u2013539","journal-title":"Neuroscientist"},{"key":"209_CR53","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/YIC.0b013e3282f2b4c5","volume":"23","author":"RN Malempati","year":"2008","unstructured":"Malempati RN, Bond DJ, Yatham LN (2008) Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients. Int Clin Psychopharmacol 23:88\u201394","journal-title":"Int Clin Psychopharmacol"},{"key":"209_CR54","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1399-5618.2011.00898.x","volume":"13","author":"R Marcus","year":"2011","unstructured":"Marcus R, Khan A, Rollin L, Morris B, Timko K, Carson W, Sanchez R (2011) Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study. Bipolar Disord 13:133\u2013144","journal-title":"Bipolar Disord"},{"key":"209_CR55","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4088\/JCP.08m04942gre","volume":"71","author":"SL Mcelroy","year":"2010","unstructured":"Mcelroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C, Nordenhem A, Young AH (2010) A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry 71:163\u2013174","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"209_CR56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1399-5618.2012.00998.x","volume":"14","author":"D Miklowitz","year":"2012","unstructured":"Miklowitz D, Price J, Holmes E, Rendell J, Bell S, Budge K, Christensen J, Wallace J, Simon J, Goodwin G, Geddes J (2012) Facilitated integrated mood management (FIMM) for adults with bipolar disorder. Bipolar Disord 14(2):185\u2013197","journal-title":"Bipolar Disord"},{"key":"209_CR57","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1001\/archpsyc.60.9.904","volume":"60","author":"DJ Miklowitz","year":"2003","unstructured":"Miklowitz DJ, George EL, Richards JA, Simoneau TL, Suddath RL (2003) A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Arch Gen Psychiatry 60:904\u2013912","journal-title":"Arch Gen Psychiatry"},{"key":"209_CR58","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/01.pra.0000314314.94791.c9","volume":"14","author":"DJ Miklowitz","year":"2008","unstructured":"Miklowitz DJ, Goodwin GM, Bauer MS, Geddes JR (2008) Common and specific elements of psychosocial treatments for bipolar disorder: a survey of clinicians participating in randomized trials. J Psychiatr Pract 14:77\u201385","journal-title":"J Psychiatr Pract"},{"key":"209_CR59","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/archpsyc.64.4.419","volume":"64","author":"DJ Miklowitz","year":"2007","unstructured":"Miklowitz DJ, Otto MW, Frank E, Reilly-Harrington NA, Wisniewski SR, Kogan JN, Nierenberg AA, Calabrese JR, Marangell LB, Gyulai L, Araga M, Gonzalez JM, Shirley ER, Thase ME, Sachs GS (2007) Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry 64:419\u2013426","journal-title":"Arch Gen Psychiatry"},{"key":"209_CR60","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1176\/appi.ajp.163.2.210","volume":"163","author":"AA Nierenberg","year":"2006","unstructured":"Nierenberg AA, Ostacher MJ, Calabrese JR, Ketter TA, Marangell LB, Miklowitz DJ, Miyahara S, Bauer MS, Thase ME, Wisniewski SR, Sachs GS (2006) Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry 163:210\u2013216","journal-title":"Am J Psychiatry"},{"key":"209_CR61","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/11538980-000000000-00000","volume":"25","author":"CU Pae","year":"2011","unstructured":"Pae CU, Forbes A, Patkar AA (2011) Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data. CNS Drugs 25:109\u2013127","journal-title":"CNS Drugs"},{"key":"209_CR62","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1399-5618.2010.00850.x","volume":"12","author":"MN Pavuluri","year":"2010","unstructured":"Pavuluri MN, Henry DB, Findling RL, Parnes S, Carbray JA, Mohammed T, Janicak PG, Sweeney JA (2010) Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder. Bipolar Disord 12:593\u2013605","journal-title":"Bipolar Disord"},{"key":"209_CR63","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0031-6997(24)01490-X","volume":"53","author":"AM Persky","year":"2001","unstructured":"Persky AM, Brazeau GA (2001) Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol Rev 53:161\u2013176","journal-title":"Pharmacol Rev"},{"key":"209_CR64","doi-asserted-by":"publisher","first-page":"680","DOI":"10.4088\/JCP.v64n0610","volume":"64","author":"RM Post","year":"2003","unstructured":"Post RM, Denicoff KD, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Rush AJ, Keck PE, Mcelroy SL, Luckenbaugh DA, Pollio C, Kupka R, Nolen WA (2003) Morbidity in 258 bipolar outpatients followed for 1\u00a0year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry 64:680\u2013690 (quiz 738\u2013739)","journal-title":"J Clin Psychiatry"},{"key":"209_CR65","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.biopsych.2010.01.015","volume":"68","author":"JA Quiroz","year":"2010","unstructured":"Quiroz JA, Yatham LN, Palumbo JM, Karcher K, Kushner S, Kusumakar V (2010) Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder. Biol Psychiatry 68:156\u2013162","journal-title":"Biol Psychiatry"},{"key":"209_CR66","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1037\/0022-006X.71.3.482","volume":"71","author":"MM Rea","year":"2003","unstructured":"Rea MM, Tompson MC, Miklowitz DJ, Goldstein MJ, Hwang S, Mintz J (2003) Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial. J Consult Clin Psychol 71:482\u2013492","journal-title":"J Consult Clin Psychol"},{"key":"209_CR67","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/j.1399-5618.2007.00532.x","volume":"9","author":"S Roitman","year":"2007","unstructured":"Roitman S, Green T, Osher Y, Karni N, Levine J (2007) Creatine monohydrate in resistant depression: a preliminary study. Bipolar Disord 9:754\u2013758","journal-title":"Bipolar Disord"},{"key":"209_CR68","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1073\/pnas.91.10.4155","volume":"91","author":"JD Rothstein","year":"1994","unstructured":"Rothstein JD, Bristol LA, Hosler B, Brown RH Jr, Kuncl RW (1994) Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc Natl Acad Sci U S A 91:4155\u20134159","journal-title":"Proc Natl Acad Sci U S A"},{"key":"209_CR69","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMoa064135","volume":"356","author":"GS Sachs","year":"2007","unstructured":"Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME (2007) Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 356:1711\u20131722","journal-title":"N Engl J Med"},{"key":"209_CR70","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/01.jcp.0000231609.91144.00","volume":"26","author":"HA Savas","year":"2006","unstructured":"Savas HA, Yumru M, Ozen ME (2006) Use of long-acting risperidone in the treatment of bipolar patients. J Clin Psychopharmacol 26:530\u2013531","journal-title":"J Clin Psychopharmacol"},{"key":"209_CR71","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1192\/bjp.188.4.313","volume":"188","author":"J Scott","year":"2006","unstructured":"Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T, Abbott R, Hayhurst H (2006) Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry 188:313\u2013320","journal-title":"Br J Psychiatry"},{"key":"209_CR72","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jad.2008.01.029","volume":"111","author":"V Sharma","year":"2008","unstructured":"Sharma V, Khan M, Corpse C (2008) Role of lamotrigine in the management of treatment-resistant bipolar II depression: a chart review. J Affect Disord 111:100\u2013105","journal-title":"J Affect Disord"},{"key":"209_CR73","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1017\/S0033291704002624","volume":"35","author":"GE Simon","year":"2005","unstructured":"Simon GE, Ludman EJ, Unutzer J, Bauer MS, Operskalski B, Rutter C (2005) Randomized trial of a population-based care program for people with bipolar disorder. Psychol Med 35:13\u201324","journal-title":"Psychol Med"},{"key":"209_CR74","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s11064-010-0195-2","volume":"35","author":"AV Steckert","year":"2010","unstructured":"Steckert AV, Valvassori SS, Moretti M, Dal-Pizzol F, Quevedo J (2010) Role of oxidative stress in the pathophysiology of bipolar disorder. Neurochem Res 35:1295\u20131301","journal-title":"Neurochem Res"},{"key":"209_CR75","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/archpsyc.56.5.407","volume":"56","author":"AL Stoll","year":"1999","unstructured":"Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB (1999) Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56:407\u2013412","journal-title":"Arch Gen Psychiatry"},{"key":"209_CR76","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/15622970701317265","volume":"9","author":"T Suppes","year":"2008","unstructured":"Suppes T, Hirschfeld RM, Vieta E, Raines S, Paulsson B (2008) Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies. World J Biol Psychiatry 9:198\u2013211","journal-title":"World J Biol Psychiatry"},{"key":"209_CR77","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1590\/S1516-44462006000300020","volume":"28","author":"CT Teng","year":"2006","unstructured":"Teng CT, Demetrio FN (2006) Memantine may acutely improve cognition and have a mood stabilizing effect in treatment-resistant bipolar disorder. Rev Bras Psiquiatr 28:252\u2013254","journal-title":"Rev Bras Psiquiatr"},{"key":"209_CR78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/jcp.0b013e3181618eb4","volume":"28","author":"ME Thase","year":"2008","unstructured":"Thase ME, Jonas A, Khan A, Bowden CL, Wu X, Mcquade RD, Carson WH, Marcus RN, Owen R (2008) Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies. J Clin Psychopharmacol 28:13\u201320","journal-title":"J Clin Psychopharmacol"},{"key":"209_CR79","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","volume":"26","author":"ME Thase","year":"2006","unstructured":"Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, Calabrese JR (2006) Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol 26:600\u2013609","journal-title":"J Clin Psychopharmacol"},{"key":"209_CR80","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1176\/appi.ajp.163.2.247","volume":"163","author":"M Tohen","year":"2006","unstructured":"Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, Baker RW, Chou JC, Bowden CL (2006) Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 163:247\u2013256","journal-title":"Am J Psychiatry"},{"key":"209_CR81","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1176\/appi.ajp.162.7.1281","volume":"162","author":"M Tohen","year":"2005","unstructured":"Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell\u2019Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL (2005) Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry 162:1281\u20131290","journal-title":"Am J Psychiatry"},{"key":"209_CR82","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","volume":"60","author":"M Tohen","year":"2003","unstructured":"Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A (2003) Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 60:1079\u20131088","journal-title":"Arch Gen Psychiatry"},{"key":"209_CR83","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4088\/JCP.08m04152","volume":"70","author":"ML Loos van der","year":"2009","unstructured":"van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA (2009) Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. J Clin Psychiatry 70:223\u2013231","journal-title":"J Clin Psychiatry"},{"key":"209_CR84","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/15622970701530917","volume":"9","author":"E Vieta","year":"2008","unstructured":"Vieta E, Nieto E, Autet A, Rosa AR, Goikolea JM, Cruz N, Bonet P (2008a) A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone. World J Biol Psychiatry 9:219\u2013224","journal-title":"World J Biol Psychiatry"},{"key":"209_CR85","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jad.2008.06.001","volume":"109","author":"E Vieta","year":"2008","unstructured":"Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M (2008b) Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord 109:251\u2013263","journal-title":"J Affect Disord"},{"key":"209_CR86","doi-asserted-by":"publisher","first-page":"769","DOI":"10.4088\/JCP.v69n0510","volume":"69","author":"RH Weisler","year":"2008","unstructured":"Weisler RH, Calabrese JR, Thase ME, Arvekvist R, Stening G, Paulsson B, Suppes T (2008) Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies. J Clin Psychiatry 69:769\u2013782","journal-title":"J Clin Psychiatry"},{"key":"209_CR87","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0447.2007.01059.x","volume":"434","author":"LN Yatham","year":"2007","unstructured":"Yatham LN, Fallu A, Binder CE (2007) A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder. Acta Psychiatr Scand Suppl 434:50\u201356","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"209_CR88","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/npp.2009.2","volume":"34","author":"SJ Yoon","year":"2009","unstructured":"Yoon SJ, Lyoo IK, Haws C, Kim TS, Cohen BM, Renshaw PF (2009) Decreased glutamate\/glutamine levels may mediate cytidine\u2019s efficacy in treating bipolar depression: a longitudinal proton magnetic resonance spectroscopy study. Neuropsychopharmacology 34:1810\u20131818","journal-title":"Neuropsychopharmacology"},{"key":"209_CR89","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4088\/JCP.08m04995gre","volume":"71","author":"AH Young","year":"2010","unstructured":"Young AH, Mcelroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M (2010) A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry 71:150\u2013162","journal-title":"J Clin Psychiatry"},{"key":"209_CR90","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.biopsych.2004.03.013","volume":"56","author":"CA Zarate Jr","year":"2004","unstructured":"Zarate CA Jr, Payne JL, Singh J, Quiroz JA, Luckenbaugh DA, Denicoff KD, Charney DS, Manji HK (2004) Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biol Psychiatry 56:54\u201360","journal-title":"Biol Psychiatry"},{"key":"209_CR91","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.biopsych.2004.11.023","volume":"57","author":"CA Zarate Jr","year":"2005","unstructured":"Zarate CA Jr, Quiroz JA, Singh JB, Denicoff KD, de Jesus G, Luckenbaugh DA, Charney DS, Manji HK (2005) An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry 57:430\u2013432","journal-title":"Biol Psychiatry"}],"container-title":["Current Topics in Behavioral Neurosciences","Behavioral Neurobiology of Depression and Its Treatment"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2012_209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T19:34:03Z","timestamp":1743968043000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/7854_2012_209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9783642354243","9783642354250"],"references-count":91,"URL":"https:\/\/doi.org\/10.1007\/7854_2012_209","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-642-35425-0","asserted-by":"object"}]},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}